IVF by Age: How Many Embryos Should You Transfer After 38 When Traveling to the U.S. for a Clinic Consultation?

When you are 38 or older and considering IVF in the United States, one of the most important questions to discuss during your clinic consultation is not simply “How many embryos can I transfer?” but “How many embryos should I transfer to maximize the chance of a healthy singleton birth while minimizing avoidable risks?”

For patients traveling internationally for a U.S. IVF consultation, embryo transfer decisions can feel confusing because the recommendation may differ from what they have heard in their home country. Some patients are told that transferring two or three embryos is “more efficient,” especially after age 38. Others are advised that one embryo is safest, especially if preimplantation genetic testing for aneuploidy, commonly called PGT-A, has identified a chromosomally normal embryo. Both statements can be true in different clinical contexts.

In modern IVF, age remains one of the strongest predictors of egg and embryo chromosomal normality. However, age alone should not determine the number of embryos transferred. A 39-year-old patient with one high-quality euploid blastocyst is in a very different situation from a 42-year-old patient transferring untested day-3 embryos, and both are different from a 44-year-old using donor eggs from a 28-year-old donor.

The U.S. approach is generally guided by a principle that many reproductive endocrinologists repeat often: the goal of IVF is one healthy baby at a time. This means that the best embryo transfer plan is not the one that produces the highest short-term positive pregnancy test at any cost, but the one that balances live birth probability, maternal safety, neonatal safety, and the patient’s reproductive timeline.

Why Age 38 Is a Turning Point in IVF Counseling

Age 38 is not a magical cutoff, but it is a clinically meaningful point because the percentage of embryos with chromosomal abnormalities increases with maternal age. These abnormalities, known as aneuploidy, are the main reason implantation rates decline and miscarriage rates rise in the late 30s and early 40s.

By the late 30s, many embryos that look “beautiful” under the microscope may still be chromosomally abnormal. Embryo grading describes appearance, expansion, inner cell mass, and trophectoderm quality, but it cannot confirm whether the embryo has the correct number of chromosomes. This is why patients over 38 often hear about PGT-A during a U.S. consultation.

However, PGT-A is not the right choice for every patient. It may be more informative when several blastocysts are available, but less helpful if only one or two embryos are expected. It also does not guarantee a baby; it helps select embryos with a higher likelihood of implantation and lower miscarriage risk. The transfer number discussion must therefore account for whether embryos are euploid, untested, mosaic, cleavage-stage, blastocyst-stage, fresh, frozen, donor-derived, or created with the patient’s own eggs.

Key clinical idea: After age 38, transferring more embryos may increase the chance of pregnancy per transfer in some untested-embryo situations, but it also increases the chance of twins or higher-order multiples. When a euploid embryo is available, transferring one embryo is usually recommended regardless of the patient’s age.

The U.S. Standard: Single Embryo Transfer When a Euploid Embryo Is Available

In the United States, many fertility clinics follow recommendations influenced by professional societies such as the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. These recommendations are not rigid laws, and individual clinics may have their own policies, but they strongly support elective single embryo transfer when the chance of implantation is high.

If PGT-A shows that an embryo is euploid, meaning chromosomally normal by the test used, then single embryo transfer is typically recommended. This is true for patients aged 38, 39, 40, 41, 42, or older, because the embryo’s chromosomal status becomes more informative than chronological age for that specific embryo transfer.

For example, a 40-year-old patient transferring one euploid blastocyst may have a meaningful chance of live birth from that single transfer. Transferring two euploid embryos may increase the twin risk substantially without doubling the chance of a healthy live birth. In fact, if two euploid embryos are available, many U.S. physicians prefer transferring one now and saving the second embryo for a later transfer if needed. This sequential strategy often provides a similar cumulative chance of live birth while reducing the risk of twin pregnancy.

Patients sometimes ask, “If I am older and have traveled so far, shouldn’t I transfer two to avoid another trip?” This is an understandable concern. Travel, cost, work leave, visas, childcare, and emotional fatigue matter. Still, from a medical perspective, transferring two strong embryos primarily changes the risk profile: it may slightly increase the chance of pregnancy in that single attempt, but it also increases the chance of twins, premature birth, pregnancy complications, and neonatal intensive care.

General Embryo Transfer Guidance After Age 38

The table below summarizes common counseling patterns used in many U.S. fertility practices. It is not a personal prescription. Your final recommendation should come from your reproductive endocrinologist after reviewing your medical history, embryo records, uterine evaluation, prior IVF outcomes, and pregnancy risk factors.

Patient / Embryo Situation	Common U.S. Recommendation	Why This Is Often Recommended
Age 38–40 with one or more euploid blastocysts	Usually transfer 1 embryo	A euploid blastocyst has relatively high implantation potential. Single transfer reduces twin risk while preserving good success rates.
Age 38–40 with untested high-quality blastocysts and favorable prognosis	Often transfer 1; sometimes 2 may be discussed	If prognosis is favorable, single transfer is often safest. Two may be considered after repeated failures, limited time, or lower embryo quality, but twin risk must be discussed.
Age 38–40 with untested poorer-quality blastocysts or prior failed transfers	1–2 embryos may be considered	Lower implantation potential may justify considering two, but the decision depends on medical safety and patient preferences.
Age 41–42 with euploid blastocyst	Usually transfer 1 embryo	Once a euploid embryo is identified, maternal age alone is not a reason to transfer two euploid embryos.
Age 41–42 with untested blastocysts	Often 1–2; occasionally more in selected poor-prognosis cases depending on clinic policy	Aneuploidy rates are higher, so implantation per embryo is lower. Still, clinics try to avoid twins and high-order multiples.
Age 43+ using own untested embryos	Highly individualized; often 1–2 blastocysts, sometimes more only under strict counseling	Many embryos may be aneuploid. Transferring more embryos does not reliably overcome age-related embryo genetics and may still create multiple pregnancy risk.
Any age using donor eggs or donor embryos from a young donor	Usually transfer 1 embryo	Embryo potential reflects egg donor age or embryo quality. Single transfer is generally preferred to reduce twin risk.
Mosaic embryo transfer	Usually transfer 1 embryo, with specialized genetic counseling	Mosaic embryo outcomes vary by type and level of mosaicism. Multiple mosaic embryo transfer is generally approached cautiously.

Important: U.S. clinics may decline to transfer more embryos than they consider medically safe, even if the patient requests it. This is especially true when euploid embryos or donor-egg embryos are available.

Why “More Embryos” Does Not Always Mean “More Success”

It is natural to think that transferring two embryos should double the chance of success. In reproductive medicine, the math is not that simple. If one embryo has a high chance of implanting, transferring two increases the chance that both implant. That means the “extra” benefit may come with a disproportionate increase in twin risk.

For patients over 38 transferring untested embryos, the issue becomes more complex. Some embryos may be chromosomally abnormal and unable to implant or continue. In that situation, transferring two may increase the probability that at least one embryo is viable. But if both are viable, a twin pregnancy can occur. Therefore, the physician must estimate not only implantation probability, but also the probability of multiple gestation.

Another reason transferring more embryos may not solve the problem is that implantation failure and miscarriage can be related to factors other than embryo number. Uterine polyps, fibroids that distort the cavity, hydrosalpinx, chronic endometritis, uncontrolled thyroid disease, poorly controlled diabetes, severe male-factor issues, and embryo-endometrium timing can all affect outcomes. If these issues are present, placing more embryos into the uterus may not address the underlying problem.

In a U.S. consultation, a good physician will usually ask: Have you had a saline sonogram or hysteroscopy? Was the embryo transfer technically easy? Were progesterone levels adequate? Were embryos blastocysts or cleavage-stage? Were they tested? What was the miscarriage karyotype, if available? These details matter more than age alone.

The Medical Risks of Twins Are Not Small, Especially After 38

Many patients feel emotionally comfortable with twins. Some even hope for twins because they want to complete their family in one pregnancy. As a physician, I understand that feeling. However, twin pregnancy is medically different from singleton pregnancy, and the risks increase further with advancing maternal age and underlying conditions.

Twin pregnancies are associated with higher rates of miscarriage, preterm birth, low birth weight, gestational diabetes, hypertensive disorders such as preeclampsia, placenta complications, cesarean delivery, postpartum hemorrhage, and neonatal intensive care admission. Babies born prematurely may face breathing problems, feeding difficulties, infection risk, developmental concerns, and prolonged hospitalization.

For patients aged 38 and older, baseline pregnancy risks are already higher than in younger patients. If there is also hypertension, diabetes, obesity, prior uterine surgery, autoimmune disease, kidney disease, or a history of severe obstetric complications, a twin pregnancy may be especially risky. This is why U.S. clinics often counsel strongly against transferring two high-quality embryos when one embryo offers a reasonable chance.

There is also a small risk that a single transferred embryo can split into identical twins. This is called monozygotic twinning. It is uncommon, but it means that even single embryo transfer cannot guarantee a singleton pregnancy. If two embryos are transferred and one splits, a triplet pregnancy can occur, although this is rare. This possibility is one reason clinics are cautious.

Age 38–40: The Most Common Counseling Scenario

Patients aged 38 to 40 often sit in the middle of the decision tree. Many still produce blastocysts, but the proportion of euploid embryos is lower than at younger ages. If PGT-A identifies a euploid embryo, single embryo transfer is commonly advised. If embryos are untested, the decision depends on embryo quality, number of embryos available, prior failures, and the patient’s tolerance for twin risk.

For a 38-year-old with three untested good-quality blastocysts and no prior failed transfers, many U.S. physicians would discuss single embryo transfer first, especially if the patient wants to avoid twins. If that transfer fails, the next embryo can be transferred later. This is called a cumulative live birth strategy.

For a 40-year-old with only two fair-quality untested blastocysts after several IVF cycles, transferring two may be discussed. The reasoning is that each embryo may have a lower chance of producing a live birth, and the patient may have limited ovarian reserve or limited time. Even then, the physician should clearly explain the risk of twins, the possibility of miscarriage, and alternatives such as PGT-A, another retrieval, donor eggs, or sequential single transfers.

Age 41–42: More Individualization, But Euploid Still Usually Means One

At ages 41 and 42, aneuploidy rates are higher, so untested embryo transfer counseling may become more flexible. If embryos are untested, some clinics may consider transferring two blastocysts, especially after previous unsuccessful transfers or in patients with a poor prognosis. However, many clinics remain cautious about transferring more than two blastocysts because twins and higher-order multiples remain possible.

If the embryo is euploid, the recommendation usually returns to single embryo transfer. This point surprises many patients. They may think, “I am 42, so I should transfer two.” But if one embryo has been tested as euploid, transferring two euploid embryos may create an unacceptably high twin risk. The uterus does not become safer for twins just because the patient is older; in fact, pregnancy complications may be more concerning.

A practical question is whether PGT-A is worthwhile at 41 or 42. The answer depends on how many blastocysts are expected. If several embryos are available, PGT-A may help prioritize transfer and reduce miscarriage risk. If only one embryo is created, some patients prefer not to biopsy and simply transfer. U.S. clinics differ in philosophy, and your consultation should include a balanced discussion rather than a one-size-fits-all recommendation.

Age 43 and Older: Transferring More Embryos Has Limits

For patients aged 43 and older using their own eggs, IVF success rates are generally lower because most embryos are chromosomally abnormal. In this context, transferring multiple untested embryos may seem logical. However, there are limits to what embryo number can achieve. If the underlying issue is embryo aneuploidy, transferring more embryos does not convert abnormal embryos into normal ones.

Some older protocols historically transferred several cleavage-stage embryos in women over 40. Modern practice has shifted because blastocyst culture, vitrification, PGT-A, and improved laboratory selection have changed the risk-benefit calculation. Many U.S. clinics are reluctant to transfer large numbers of embryos, especially blastocysts, because even at older ages a multiple pregnancy can occur.

At 43 or older, your consultation may include a frank discussion about prognosis with own eggs versus donor eggs. This conversation can be emotionally difficult. A compassionate physician should not pressure you, but should provide realistic numbers. If donor eggs are used, embryo potential reflects the donor’s age and embryo quality, not the recipient’s age. Therefore, donor-egg embryo transfer is usually single embryo transfer, even if the recipient is 44, 45, or older, provided pregnancy is medically safe.

Fresh Transfer Versus Frozen Transfer: Does It Change the Number?

The number of embryos transferred may also depend on whether the transfer is fresh or frozen. In a fresh transfer, embryos are placed in the uterus during the same cycle as ovarian stimulation and egg retrieval. In a frozen embryo transfer, embryos are cryopreserved and transferred later in a prepared or natural cycle.

Many U.S. clinics increasingly use frozen embryo transfer, especially when PGT-A is performed, progesterone is elevated during stimulation, the patient is at risk for ovarian hyperstimulation syndrome, or the clinic prefers to optimize the uterine environment later. Frozen transfer also allows travel planning. International patients may complete ovarian stimulation and retrieval in the U.S., return home, and come back for frozen embryo transfer after PGT-A results are available.

Does frozen transfer mean fewer embryos should be transferred? Not automatically, but frozen transfer is often associated with better planning and clearer embryo selection. If a euploid frozen blastocyst is available, single embryo transfer is generally recommended. If frozen embryos are untested, the decision still depends on age at egg retrieval, embryo quality, prior history, and clinic policy.

What to Bring to a U.S. IVF Consultation After 38

If you are traveling to the United States for a fertility consultation, preparation is essential. The doctor can give a more precise embryo transfer recommendation when your records are complete. Many patients lose valuable consultation time because embryo reports are missing or unclear.

Questions to Ask the U.S. Fertility Clinic

During your consultation, you should feel comfortable asking direct questions. The best clinics welcome informed patients. If the recommendation is to transfer one embryo, ask why. If the recommendation is to transfer two, ask how the clinic estimates twin risk and what safety factors they considered.

Based on my age and embryo type, how many embryos do you recommend transferring?
Is your recommendation different if the embryo is euploid, mosaic, or untested?
What is my estimated chance of live birth with one embryo versus two?
What is my estimated risk of twins if we transfer two embryos?
Would sequential single embryo transfer give a similar cumulative chance with lower risk?
Does my medical history make twin pregnancy unsafe?
Do you follow ASRM or SART embryo transfer guidance?
What is your clinic policy on transferring two euploid embryos?
If I am traveling internationally, how many days must I stay for monitoring and transfer?
Can some monitoring be performed in my home country before I travel?

These questions shift the conversation from emotion to evidence. They also help you understand whether the clinic is personalizing care or applying a generic protocol.

Travel Logistics Can Influence Decisions, But Should Not Override Safety

International patients often face unique pressures. A patient who lives locally can return for another frozen transfer more easily than someone flying from another continent. Hotel costs, time off work, visa issues, and uncertainty about cycle timing can make patients prefer a more aggressive transfer plan.

U.S. clinics understand these challenges. Many clinics offer remote consultations before travel, coordinate local monitoring with physicians in the patient’s home country, and schedule frozen embryo transfer in a predictable window. Some patients only need to arrive a few days before transfer, while others may need longer stays depending on the protocol and clinic requirements.

However, travel inconvenience should not be the primary reason to transfer more embryos than medically advisable. A twin pregnancy can create far greater medical, financial, and emotional burdens than a second trip. Premature twins may require prolonged neonatal care, and pregnancy complications can restrict travel later. In severe cases, patients may be unable to return home when planned.

If travel is the main concern, discuss alternatives: batching embryos, freezing and transferring one at a time, arranging local monitoring, using a predictable medicated frozen transfer cycle, or planning two possible transfer windows. The clinic’s international coordinator can often help with timelines.

How PGT-A Changes the Conversation After 38

PGT-A is commonly discussed after age 38 because the proportion of aneuploid embryos rises with age. The potential benefits include better embryo prioritization, lower miscarriage risk per transfer, fewer transfers of embryos unlikely to work, and greater confidence in single embryo transfer. But PGT-A also has limitations.

First, PGT-A requires embryo biopsy, usually at the blastocyst stage. Not every embryo reaches blastocyst. Second, the result reflects the sampled trophectoderm cells, not the entire embryo. Third, mosaic results can be complex. Fourth, testing adds cost and may not improve outcomes for every patient, especially those with very few embryos.

When PGT-A identifies a euploid embryo, it gives the doctor stronger justification to recommend single embryo transfer. When all embryos are aneuploid, transfer is usually not recommended, although specific policies vary. When mosaic embryos are present, transfer may be possible after genetic counseling, but most clinics prefer transferring one mosaic embryo at a time.

For patients traveling to the United States, PGT-A may also affect timing. Many clinics perform egg retrieval, fertilization, blastocyst culture, biopsy, freezing, and then wait for results before scheduling transfer. This often means the transfer occurs in a later cycle, not during the same trip unless the patient remains in the U.S. for an extended period.

Embryo Stage Matters: Day-3 Embryos Versus Blastocysts

When discussing embryo number, it is important to know whether embryos are cleavage-stage embryos, usually day 2 or day 3, or blastocysts, usually day 5, day 6, or sometimes day 7. Blastocysts have already passed additional developmental milestones, so each blastocyst generally has a higher implantation potential than each cleavage-stage embryo.

Because of this, guidelines historically allowed more cleavage-stage embryos than blastocysts. For example, transferring three day-3 embryos is not biologically equivalent to transferring three high-quality blastocysts. Three blastocysts can carry a much higher multiple pregnancy risk.

Many U.S. clinics prefer blastocyst transfer because it allows better embryo selection and is compatible with trophectoderm biopsy for PGT-A. However, some patients, especially those with few embryos, may choose day-3 transfer. If you are over 38 and considering day-3 transfer, your doctor will discuss how many embryos to transfer based on embryo number, quality, prior outcomes, and the clinic’s experience.

Donor Eggs, Donor Embryos, and Recipient Age

A common misunderstanding is that the recipient’s age determines the embryo transfer number in donor-egg IVF. In reality, embryo potential is strongly influenced by the age and quality of the eggs used to create the embryos. If a 44-year-old recipient uses eggs from a 27-year-old donor, the embryo’s chromosomal risk is closer to the donor’s age than the recipient’s age.

Therefore, single embryo transfer is usually recommended for donor-egg embryos, especially if the embryo is a good-quality blastocyst or euploid. Transferring two donor-egg embryos can create a high twin risk. Before proceeding, recipients in their 40s should also have appropriate medical clearance to ensure pregnancy is safe, particularly if there is hypertension, diabetes, heart disease, kidney disease, or a history of pregnancy complications.

Donor embryo transfer follows similar logic. If the donor embryo was created from young eggs and is high quality, single embryo transfer is typically safest. If the embryo is older, untested, or lower quality, the recommendation may vary, but many clinics still prioritize singleton pregnancy.

What If You Strongly Want Twins?

It is common for patients to say, “I would be happy with twins.” This statement deserves respect, but it also requires detailed counseling. Wanting twins emotionally is different from understanding the medical risks of twins. Fertility specialists are responsible not only for helping patients become pregnant, but also for reducing preventable harm.

If you strongly prefer twins, your physician may recommend a consultation with a maternal-fetal medicine specialist, especially if you are over 38 or have medical risk factors. This high-risk pregnancy doctor can explain twin pregnancy monitoring, preterm birth risk, delivery planning, and possible complications. Some patients change their preference after understanding the risks more clearly.

Ultimately, a clinic may still decline to transfer two euploid embryos or two donor-egg embryos, even if you accept the risk. Medical ethics in IVF include the welfare of the future child or children, not only the patient’s preference.

A Practical Decision Framework

For patients over 38 traveling to the U.S., the following framework can help organize the decision before consultation:

Step	Question	How It Affects Embryo Number
1	Are the embryos euploid by PGT-A?	If yes, single embryo transfer is usually recommended.
2	Were the eggs from you or a donor?	Donor-egg embryos usually support single transfer because implantation potential is higher.
3	Are embryos blastocysts or day-3 embryos?	Blastocysts generally require more caution because each embryo has higher implantation potential.
4	What is your obstetric risk if twins occur?	High-risk patients should usually avoid transferring two embryos when possible.
5	How many embryos are available?	If multiple embryos exist, sequential single transfers may be safer. If only one or two poor-prognosis embryos exist, transfer number may be individualized.
6	What happened in previous transfers?	Repeated failures may justify deeper evaluation before simply increasing embryo number.
7	Can you return for another transfer if needed?	Travel limitations matter, but safety should remain central.

Common Examples

Example 1: 39 years old, two euploid blastocysts

A 39-year-old patient has two euploid blastocysts after PGT-A. In many U.S. clinics, the recommendation would be to transfer one embryo and freeze the other. If the first transfer does not result in live birth, the second can be transferred later. This approach maintains a strong cumulative chance while reducing twin risk.

Example 2: 40 years old, two untested blastocysts, prior failed transfer

A 40-year-old patient has two untested fair-quality blastocysts and one prior failed transfer. The clinic may discuss either single transfer or transfer of two embryos, depending on the patient’s medical safety and preferences. The doctor should explain that transferring two may increase the chance of pregnancy in that attempt, but also creates a real twin risk if both embryos are viable.

Example 3: 42 years old, one euploid embryo

A 42-year-old patient has one euploid embryo. The decision is straightforward: transfer one, because only one is available. If more euploid embryos were available, transferring one at a time would still generally be recommended.

Example 4: 44 years old using donor eggs

A 44-year-old patient uses donor eggs from a 29-year-old donor and creates several high-quality blastocysts. The typical U.S. recommendation would be single embryo transfer. The recipient’s age makes pregnancy monitoring important, but it does not justify transferring two strong donor-egg embryos.

Final Takeaway

After age 38, the right number of embryos to transfer during IVF depends on embryo genetics, embryo stage, embryo quality, prior treatment history, uterine factors, medical safety, and your personal goals. In the United States, the strongest trend is toward single embryo transfer whenever there is a high-quality euploid embryo or donor-egg embryo. For untested embryos in patients aged 38 to 42, transferring one or two may be discussed depending on prognosis, but the decision should be individualized and carefully documented.

If you are traveling to the U.S. for a clinic consultation, arrive prepared with complete records and clear questions. Ask your doctor not only what they recommend, but why they recommend it for your specific case. A safe IVF plan should respect your time, finances, and emotional investment, while keeping the central goal in focus: one healthy baby and one healthy parent at a time.

Medical disclaimer: This article is for general educational purposes and does not replace individualized medical advice. Embryo transfer decisions should be made with a licensed reproductive endocrinologist who has reviewed your complete medical and embryology records.